OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Individualized prevention of proton pump inhibitor related adverse events by risk stratification
Bin Xia, Qiangsheng He, Fang Gao Smith, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Bin Xia, Qiangsheng He, Fang Gao Smith, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Showing 7 citing articles:
Proton pump inhibitors and cancer treatments: Emerging evidence against coadministration
Jean‐Luc Raoul, Philip D. Hansten
Cancer Treatment Reviews (2024) Vol. 129, pp. 102794-102794
Closed Access | Times Cited: 2
Jean‐Luc Raoul, Philip D. Hansten
Cancer Treatment Reviews (2024) Vol. 129, pp. 102794-102794
Closed Access | Times Cited: 2
Defining Clinical Characteristics of Individuals With and Without Post‐Bariatric Hypoglycemia After Gastric Bypass
Ashna Grover, Maryam Farahmandsadr, Hamayle Saeed, et al.
Clinical Endocrinology (2024)
Closed Access | Times Cited: 2
Ashna Grover, Maryam Farahmandsadr, Hamayle Saeed, et al.
Clinical Endocrinology (2024)
Closed Access | Times Cited: 2
Widening spectrum of adverse effects caused by long-term use of proton pump inhibitors: A comprehensive review of literature
AS Mir, Zahoor A. Wani, Ajmal R. Baht, et al.
LabMed discovery. (2024), pp. 100027-100027
Open Access | Times Cited: 1
AS Mir, Zahoor A. Wani, Ajmal R. Baht, et al.
LabMed discovery. (2024), pp. 100027-100027
Open Access | Times Cited: 1
Unveiling the Association between Proton Pump Inhibitors and Ischaemic Stroke Using Three Sccs Approaches
Min Fan, Joseph E. Blais, Ian Chi Kei Wong, et al.
(2024)
Closed Access
Min Fan, Joseph E. Blais, Ian Chi Kei Wong, et al.
(2024)
Closed Access
Implementing pharmacogenetic testing to optimize proton-pump inhibitors use among Indian population based on CPIC-CYP2C19-PPI dosing guidelines: The need of the hour
Santenna Chenchula, Shubham Atal, Ratinder Jhaj, et al.
Indian Journal of Pharmacology (2024) Vol. 56, Iss. 4, pp. 277-284
Closed Access
Santenna Chenchula, Shubham Atal, Ratinder Jhaj, et al.
Indian Journal of Pharmacology (2024) Vol. 56, Iss. 4, pp. 277-284
Closed Access
ADVERSE EVENTS in PATIENTS with CARDIOVASCULAR DISEASE TAKING PROTON PUMP INHIBITORS
Aitor Lanas-Gimeno, Ángel Lanas
Expert Opinion on Drug Safety (2024)
Closed Access
Aitor Lanas-Gimeno, Ángel Lanas
Expert Opinion on Drug Safety (2024)
Closed Access
Classification and identification of risk factors for type 2 diabetes
Shanshan Tang, Xuefei Zhao, Xuedong An, et al.
World Journal of Diabetes (2024) Vol. 16, Iss. 2
Closed Access
Shanshan Tang, Xuefei Zhao, Xuedong An, et al.
World Journal of Diabetes (2024) Vol. 16, Iss. 2
Closed Access
